Immune thrombocytopenia (ITP) is an autoimmune disease characterized by low platelet counts of <100 × 10 9 /L with the absence of other blood count abnormalities. Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 which is manifested by a severe multisystemic disease. We present the case of a 76-year-old female who presented with ITP associated with COVID-19 and successfully managed with intravenous immunoglobulin and glucocorticoids.
All Keywords
【저자키워드】 COVID-19, Intravenous immunoglobulin, glucocorticoid, thrombocytopenia, Immune thrombocytopenia, 【초록키워드】 Glucocorticoids, coronavirus, Autoimmune disease, female, Platelet, disease, Blood, acute respiratory syndrome, caused, characterized, absence, manifested, severe multisystemic, with COVID-19, 【제목키워드】 secondary,
【저자키워드】 COVID-19, Intravenous immunoglobulin, glucocorticoid, thrombocytopenia, Immune thrombocytopenia, 【초록키워드】 Glucocorticoids, coronavirus, Autoimmune disease, female, Platelet, disease, Blood, acute respiratory syndrome, caused, characterized, absence, manifested, severe multisystemic, with COVID-19, 【제목키워드】 secondary,